Krebs Biochemicals and Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
KREBSBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Krebs Biochemicals has informed the exchanges that the trading window for its securities will remain closed starting from the end of business on September 30, 2025. The window will stay shut until 48 hours after the company declares its unaudited financial results for the second quarter and half year ending September 30, 2025. During this period, promoters, directors, designated persons, their immediate relatives, and all connected persons are barred from trading in the company's shares. The exact date of the board meeting to approve these results will be communicated to the exchanges later.
This is a routine regulatory compliance filing and does not have a direct impact on the stock price. It signals that Q2 FY26 results are likely to be announced soon, and insiders are restricted from trading ahead of the announcement.